Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and manufacturing of branded and generic pharmaceutical products for domestic and international markets.
Ticker code: MYX
Sector: Healthcare | Industry: Drug Manufacturers – General | Website: https://www.maynepharma.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $259,986,650 | $200,854,650 | 81245827 | 84.38 | $219,387,136 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $370,318,489 | $100,403,000 | $41,271,000 | -1.8 | 11.0 | -16.0 | 15.7 |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 41.2 | $967,734 | $1,661,155 | 1.01 | 1.6 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | 2023-01-18 | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $3.200 | None | -6.2 | -30.6 | -39.4 | -36.3 | -35.9 |
MYX Price Chart with Volume and 3EMA
MYX Short Positions
Click HERE to understand why the above moving averages have been chosen.